An observational study in Burn, sponsored by Samsun University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Samsun University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 43 studies in Burns with a site in Turkey — 13 open to participants now, 17 under way, none of them phase 3. Burns · Turkey.
Among the 43 studies in Burns with a site in Turkey, this one is the 2nd largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2020, is one of 10 observational ones, reaches primary completion later than 5 of the 16 other live ones, and was the 41st registered.
906 studies on the registry are indexed under Burns; 165 are open to participants now.
Browse Burns studies →13 of the 43 studies in Burns with a site in Turkey are open now. Recruiting first, the newest first:
Necmettin Erbakan University · Sites in Turkey
Ages 18+
Ataturk University · Sites in Turkey
Ages 3–12 · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18+
Marmara University · Sites in Turkey
Ages 18+
Hasan Kalyoncu University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 87 Burns studies recruiting now, 38 (44%) set no upper age limit and 38 (44%) stop at 75 or younger; 17 take children under 18; 10 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
43 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 4 started in 2020.
This study's planned enrollment of 500 is above the median of 64 across 163 observational studies indexed under Burns.
Median enrollment 60 across the 33 interventional studies, 97 across the 10 observational. Of the 25 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 43 has an industry lead sponsor. The 10 most frequent:
Samsun University is the lead sponsor of 90 studies on the registry; 21 are open to participants now.
Samsun University has 2 studies filed under Burns — fewer than ten, so there is no comparison to draw.
2 of the studies in Burns with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07906834Samsun UniversityEffect of Short-Video Distraction During Burn Dressing on Anxiety, Pain, and Fear in Children | 2027-02 |
| NCT07386821Hacettepe UniversityEffect of Laughie on Pain Anxiety and Pain Level in Second-Degree Burn Patients | 2027-02 |
Add all 2 to your calendar (.ics) → With an account.
Among the 43 studies in Burns with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This retrospective study aims to evaluate the prognostic value of systemic inflammatory markers, specifically the C-reactive protein-to-lymphocyte ratio (CLR) and neutrophil-to-lymphocyte ratio (NLR), in patients admitted to the burn intensive care unit. Burn injury triggers a profound systemic inflammatory response, which significantly influences clinical outcomes. By analyzing medical records, the study investigates whether admission or dynamic changes in CLR and NLR correlate with the length of hospital stay (LOS) and in-hospital mortality. The ultimate goal is to identify cost-effective, readily available biomarkers for early risk stratification in severe burn management.
Severe burn injuries induce a complex pathophysiology characterized by extensive tissue damage, systemic inflammation, hypermetabolism, and immune dysregulation. Early assessment of disease severity and risk stratification is critical for optimizing treatment strategies and improving patient survival in burn units. Traditional scoring systems often require multiple parameters, whereas routine complete blood counts and inflammatory markers offer rapid, cost-effective alternatives.
This retrospective observational cohort study evaluates the clinical utility of the C-reactive protein-to-lymphocyte ratio (CLR) and the neutrophil-to-lymphocyte ratio (NLR) as prognostic indicators in adult patients treated in the burn intensive care unit.
Study Objectives:
Primary Objective: To evaluate the association between admission CLR and NLR values and overall in-hospital mortality among burn unit patients.
Secondary Objective: To determine the relationship between initial/longitudinal CLR and NLR dynamics and the total length of hospital stay (LOS), length of ICU stay, and complication rates (e.g., sepsis, acute kidney injury).
Methodology:
Patient data will be extracted retrospectively from hospital electronic medical records. Laboratory parameters-including complete blood count (neutrophil and lymphocyte counts) and C-reactive protein (CRP) levels measured upon admission (and at predefined intervals, if applicable)-will be recorded to calculate CLR and NLR values. Demographic data (age, sex), clinical variables (total body surface area burned [TBSA], burn depth, inhalation injury status, etiology of burn) and clinical outcomes (LOS and mortality) will be documented.
The study population consists of adult patients (aged 18 years and older) who were admitted to the Burn Intensive Care Unit (BICU) of Samsun Training and Research Hospital between January 2020 and December 2025. Patient data will be extracted retrospectively from electronic medical records. Eligible participants are those with confirmed acute burn injuries whose routine laboratory investigations (complete blood count and C-reactive protein) were performed upon admission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Adult patients (≥18 years) admitted to the burn intensive care unit whose medical records, including complete blood counts and CRP levels, are evaluated retrospectively.
Other: Routine blood samples collected for CRP, neutrophil, and lymphocyte counts during ICU admission.
Routinely checked complete blood count and biochemistry tests
In-Hospital Mortality
Evaluation of the association between baseline CRP/lymphocyte ratio (CLR) and neutrophil/lymphocyte ratio (NLR) values upon admission and the occurrence of all-cause in-hospital mortality.
Time frame: 01.01.2020 - 31.12.2025
Plan to share: No — No information will be shared, in order to protect the patient's personal data.
Ran from Jan 2020 to primary completion in Dec 2025, 71 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Samsun University